Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Phenotypic variability in developmental coordination disorder: Clustering of generalized joint hypermobility with attention deficit/hyperactivity disorder, atypical swallowing and narrative difficulties.

Celletti C, Mari G, Ghibellini G, Celli M, Castori M, Camerota F.

Am J Med Genet C Semin Med Genet. 2015 Mar;169C(1):117-22. doi: 10.1002/ajmg.c.31427.

PMID:
25821095
2.

Connective tissue, Ehlers-Danlos syndrome(s), and head and cervical pain.

Castori M, Morlino S, Ghibellini G, Celletti C, Camerota F, Grammatico P.

Am J Med Genet C Semin Med Genet. 2015 Mar;169C(1):84-96. doi: 10.1002/ajmg.c.31426. Epub 2015 Feb 5. Review.

PMID:
25655119
3.

Neurodevelopmental attributes of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type: Update and perspectives.

Ghibellini G, Brancati F, Castori M.

Am J Med Genet C Semin Med Genet. 2015 Mar;169C(1):107-16. doi: 10.1002/ajmg.c.31424. Epub 2015 Feb 5. Review.

PMID:
25654988
4.

Re-writing the natural history of pain and related symptoms in the joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.

Castori M, Morlino S, Celletti C, Ghibellini G, Bruschini M, Grammatico P, Blundo C, Camerota F.

Am J Med Genet A. 2013 Dec;161A(12):2989-3004. doi: 10.1002/ajmg.a.36315. Epub 2013 Nov 6. Review.

PMID:
24254847
5.

Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs.

Pfeifer ND, Goss SL, Swift B, Ghibellini G, Ivanovic M, Heizer WD, Gangarosa LM, Brouwer KL.

CPT Pharmacometrics Syst Pharmacol. 2013 Jan 2;2:e20. doi: 10.1038/psp.2012.21.

6.

Mathematical modelling of [¹¹C]-(+)-PHNO human competition studies.

Searle GE, Beaver JD, Tziortzi A, Comley RA, Bani M, Ghibellini G, Merlo-Pich E, Rabiner EA, Laruelle M, Gunn RN.

Neuroimage. 2013 Mar;68:119-32. doi: 10.1016/j.neuroimage.2012.11.033. Epub 2012 Nov 30.

PMID:
23207573
7.

Bupropion has no effect on intraocular pressure or other ophthalmologic parameters after single or repeat doses in healthy volunteers.

Ghibellini G, Park J, Brittain CF, Iavarone L, Andorn AC, Levy N, Muir KT.

J Clin Pharmacol. 2009 Apr;49(4):489-95. doi: 10.1177/0091270008330981. No abstract available.

PMID:
19318697
8.

Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.

Ghibellini G, Leslie EM, Pollack GM, Brouwer KL.

Pharm Res. 2008 Aug;25(8):1851-60. doi: 10.1007/s11095-008-9597-0. Epub 2008 May 30.

10.

In vitro-in vivo correlation of hepatobiliary drug clearance in humans.

Ghibellini G, Vasist LS, Leslie EM, Heizer WD, Kowalsky RJ, Calvo BF, Brouwer KL.

Clin Pharmacol Ther. 2007 Mar;81(3):406-13. Epub 2007 Jan 18.

PMID:
17235333
11.

In vitro and in vivo determination of piperacillin metabolism in humans.

Ghibellini G, Bridges AS, Generaux CN, Brouwer KL.

Drug Metab Dispos. 2007 Mar;35(3):345-9. Epub 2006 Dec 28.

12.

Determination of the biliary excretion of piperacillin in humans using a novel method.

Ghibellini G, Vasist LS, Hill TE, Heizer WD, Kowalsky RJ, Brouwer KL.

Br J Clin Pharmacol. 2006 Sep;62(3):304-8.

13.

Methods to evaluate biliary excretion of drugs in humans: an updated review.

Ghibellini G, Leslie EM, Brouwer KL.

Mol Pharm. 2006 May-Jun;3(3):198-211. Review.

14.

A novel method for the determination of biliary clearance in humans.

Ghibellini G, Johnson BM, Kowalsky RJ, Heizer WD, Brouwer KL.

AAPS J. 2004 Nov 23;6(4):e33.

Supplemental Content

Loading ...
Support Center